medigraphic.com
ISSN 1561-3119 (Electronic)

2013, Number 4

<< Back Next >>

Rev Cubana Pediatr 2013; 85 (4)

Some biochemical variables analyzed in obese adolescents with history of low birthweight

Valdés AMC, Rodríguez SA, Basain VJM, Piñeiro LR, de Guevara CAL

Language: Spanish
References: 28
Page: 439-447
PDF size: 141.04 Kb.


ABSTRACT

Introduction: intrauterine malnutrition has been considered as being related to embrionary development problems that determine further occurrence of obesity, diabetes mellitus type 2, dyslipidemias, mitochondrial dysfunction and atherosclerosis.
Objective: to determine the metabolic complications in obese adolescents with history of low birthweight.
Methods: cross-sectional descriptive study of 50 obese patients of both sexes and aged 9 to 17 years and with a history of low birthweight. They had all been attended to in the outpatient endocrinology service of "Juan Manuel Marquez" teaching pediatric hospital from January 2011 to January 2012. Cholesterol, triglyceride, hepatic aminotransferase, glycemia and insulinemia on fasting and postprandially after 2 hours were estimated.
Results: the studied biochemical variables did not show differences among the cutoffs used to classify birthweight. Piruvic gluthamic transaminase showed higher values in 15-17 years-old adolescents.
Conclusions: hypertriglyceridemia was more elevated in females whereas hyperglycemia and hyperinsulinemia were elevated in males.


REFERENCES

  1. Leduc L, Levy E, Bouity-Voubou M, Delvin E. Fetal programming of atherosclerosis: possible role of the mitochondria. Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):127-30.

  2. Sifianou P. Approaching the diagnosis of growth-restricted neonates: a cohort study. BMC Pregnancy Childbirth. 2010 Feb 1;10:6.

  3. Elizabeth K, Krishnan V, Vijayakumar T. Umbilical cord blood nutrients in low birth weight babies in relation to birth weight & gestational age. Indian J Med Res. 2008;128(2):128-33.

  4. Gondelberg RC, Hauty JC, Andrews WV. Intrauterine infections and preterm birth. N England J Med. 2000;342:18007.

  5. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud; 2010. Estructura de la población cubana por edad y sexo. La Habana [homepage en Internet]. 2011 [citado 22 de enero de 2012]. Disponible en: http://files.sld.cu/dne/files/2011/04/anuario-2010-e-sin-graficos1.pdf.

  6. Carballo R. Bajo peso al nacer como señal aterogénica precoz [tesis para optar por el título de máster en Investigación en Aterosclerosis]. La Habana; 2009.

  7. Jordan JR. Desarrollo humano en Cuba. La Habana: Editorial Científico-Técnica; 1979. p. 35-210.

  8. Esquivel M, Rubí A. Curvas nacionales de peso y talla. Su interpretación y uso en la valoración del estado nutricional Rev Cubana Pediatr. 1985;57(7):377-83.

  9. Barker DJP. In utero programming of chronic disease. Clinical Science. 1998;95:115-28.

  10. Neel JV. The "thrifty genotype" in 1998. Nutr Rev. 1999;57:2-9.

  11. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010;10:318.

  12. De Ferranti SD, Crean S, Cotter J, Boyd D, Osganian SK. Hypertriglyceridemia in a pediatric referral practice: experience with 300 patients. Clin Pediatr (Phila). 2011 Apr;50(4):297-307.

  13. Ho TF. Cardiovascular risks associated with obesity in children and adolescents. Ann Acad Med Singapore. 2009;38(1):48-9.

  14. Abrams P, Levitt Katz LE. Metabolic effects of obesity causing disease in childhood. Curr Opin Endocrinol Diabetes Obes. 2011;18(1):23-7.

  15. Jover E. Dislipemia y obesidad. Documento de Consenso. Sociedad Española de Endocrinología y Nutrición [homepage en Internet]. 2009 [citado 12 de enero de 2012]. Disponible en: http://www.seedo.es/cons_intro.htm

  16. Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J Gastroenterol. 2011;17(6):735-42.

  17. González Pérez B, Salas Flores R. Esteatosis hepática en niños obesos. Revista de Endocrinología y Nutrición. 2008;16(2):74-82.

  18. Bavdekar A, Yajnik CS, Fall C, Bapat S, Pandit A, Deshpande V. Insuline resistance syndrome in 8 years old indian children: small at birth, big at 8 years old, or both? Diabetes. 1999;48:2422-9.

  19. Aguilar SCA, Velázquez MO, Gómez PFJ, González CA, Esqueda AL, Molina CV, et al. Encuesta Nacional de Salud 2000 Group. Characteristics of patients with type 2 Diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care. 2003;26(7):2021-6.

  20. Brunt E. Pathologic spectrum of fatty liver disease. Liver disease in the 21st century. Clinical-pathologic correlates. AASLD Postgraduate course. 2003:65-74.

  21. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-10.

  22. Medina Alí F, Medina Arango RJ, Ruiz de Villa Martínez E, Gutiérrez Macías A. Caracterización clínica y bioquímica de la obesidad en niños y adolescentes. Ciencias Holguín [serie en Internet]. 2010 [citado 22 de enero de 2012];16(4). Disponible en: http://cienciahlg.idict.cu/index.php/cienciasholguin/article/view /624

  23. Guzzaloni G, Grugni G, Minocci A. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glicemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord. 2000;24:772-6.

  24. Silverman JF, O'Brien KF, Long S. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol. 1990;85:1349-55.

  25. Barisio D'Angelo MG, Mariel Actis A, Outomuro D. Hígado graso no alcohólico: una entidad cada vez más frecuente y de pronóstico incierto. Rev gastroenterol. 2009;29(1):19-24.

  26. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71-9.

  27. Dei Cas A, Spigoni V, Metra M, Dei Cas L. Insulin-resistance and cardiovascular risk. G Ital Cardiol (Rome). 2010;11(10 Supply 1):935-75.

  28. Méndez Sánchez N, Chávez-Tapia NC, Uribe M. Hígado graso no alcohólico. Nuevos conceptos. Rev invest clín México. 2004;56(1):15-9.




2020     |     www.medigraphic.com